Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Acute Lymphoblastic Leukemia in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Acute lymphoblastic leukemia excluding known mature B-cell ALL by the presence of any of the following: surface immunoglobulin, L3 morphology, t(8;14) (q24;q32), t(8;22) or t(2;8)~* Age \> 12 months but less than 18 years~Exclusion Criteria:~* Prior therapy except, 1 week of steroids, or emergent radiation therapy to the mediastinum~* Known HIV positive

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Individualized ASP dose (Type: EXPERIMENTAL): None
- Fixed dose ASP (Type: ACTIVE_COMPARATOR): None
- Dexamethasone (Type: EXPERIMENTAL): None
- Prednisone (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).